Skip to content

Comparison of the Effectiveness of Selective and Family-Based Prevention on Risk and Protective Factors of Substance Use in High-Risk Adolescents and Their Parents

Comparison of the Effectiveness of Selective and Family-Based Prevention on Risk and Protective Factors of Substance Use in High-Risk Adolescents and Their Parents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211223053494N1
Enrollment
60
Registered
2022-02-01
Start date
2022-04-21
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism and drug addiction in family. Alcoholism and drug addiction in family

Interventions

Intervention 1: First Intervention group: Selective prevention: The prevention package that the selective prevention intervention group receives was prepared and compiled in 10 two-hour sessions based

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: Willingness to cooperate and conscious satisfaction Living in Tehran Age range 12 to 18 years adolescent Hospitalization of one of the parents of substance-dependent children in accommodation centers and diagnosis of substance abuse disorder based on DSM 5 Do not suffer from intellectual disability No disorders of the psychotic spectrum Do not contradict the schedule of students' school classes with counseling sessions and high school students

Exclusion criteria

Exclusion criteria: Absence of more than one session of training sessions Need to receive psychological counseling or psychiatric medication during the intervention because of the potential impact on psychological symptoms Any illness that prevents the subject from cooperating

Design outcomes

Primary

MeasureTime frame
Score of risk factors and protectors against substance use in Mohammadkhani questionnaire. Timepoint: At the beginning of the study (before the intervention), after the intervention and 6 months after the intervention. Method of measurement: Questionnaire of risk factors and protection against drug use Mohammadkhani.;Addiction Talent Score in Zeinali Questionnaire. Timepoint: At the beginning of the study (before the intervention), after the intervention and 6 months after the intervention. Method of measurement: Zeinali Addiction Talent Questionnaire.;Companionship score with juvenile delinquent peers in Paschall et al.'s questionnaire. Timepoint: At the beginning of the study (before the intervention), after the intervention and 6 months after the intervention. Method of measurement: Questionnaire of companionship with juvenile delinquent Paschall et al.;Self-esteem score on the Cooper Smith Inventory. Timepoint: At the beginning of the study (before the intervention), after the intervention and 6 months after the intervention. Method of measurement: Cooper Smith Self Esteem Inventory.;Social skills score in Matson questionnaire. Timepoint: At the beginning of the study (before the intervention), after the intervention and 6 months after the intervention. Method of measurement: Matson Social Skills Questionnaire.;Iranian Adolescents Risk-Taking score in (IARS) Scale. Timepoint: At the beginning of the study (before the intervention), after the intervention and 6 months after the intervention. Method of measurement: Iranian Adolescents Risk-Taking Scale (IARS).;Child Behavioral Problems Score 6 18 on the CBCL Scale. Timepoint: At the beginning of the study (before the intervention), after the intervention and 6 months after the intervention. Method of measurement: CBCL Child Behavioral Problems Questionnaire 6 18.;Family performance score in Epstein, Baldwin and Bishop questionnaire. Timepoint: At the beginning of the study (before the intervention), after the inte

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Bakhtiari

Shahid Beheshti University of Medical Sciences

dr.m.bakhtiari@gmail.com+98 21 2303 1548

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026